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Introduction: Diseases caused by Streptococcus pneumoniae generate substantial morbidity 
and mortality. Despite official recommendations to vaccinate everyone over the age of 64, the 
estimated vaccination rate for this target population is around 2%. In Switzerland, pneumococcal 
vaccinations are for the most part provided by general practitioners (GPs); in addition, a 
small number of patients get vaccinated during a hospital stay. We wanted to investigate GPs’ 
attitudes and opinions about the pneumococcal vaccination in primary care and why it is so 
rarely provided.
Methods: For this qualitative study, we conducted semistructured interviews with 20 GPs. 
Transcriptions of all interviews were analyzed following the technique of qualitative content 
analysis, supported by the ATLAS.ti© software.
Results: Most GPs reported that they know pneumococcal vaccination is recommended for 
several risk groups and elderly patients. As to reasons for the low vaccination rate, GPs mentioned 
the pneumococcal vaccination had little priority in daily practice, especially in comparison with 
the importance of other vaccinations, namely influenza. This low level of priority was supported 
by the fact that the GPs rarely ever experienced a case of a severe pneumococcal disease in their 
daily work. Furthermore, perceived insufficient evidence resulting from existing epidemiologic 
data and clinical trials enhanced the little attention given to the pneumococcal vaccination.
Conclusion: We found the generally low level of priority given within a consultation, the 
missing awareness of this subject in daily practice, and the perception of epidemiologic and 
scientific data as insufficient, as the reasons for the low rate in pneumococcal vaccinations. 
Efforts to increase the epidemiologic data on the pneumococcal vaccination should be taken. 
To increase the vaccination rate, it would be necessary to raise the awareness and priority of 
the pneumococcal vaccination; a feasible way could be the combination of the seasonal flu 
vaccination campaign with a campaign for pneumococcal vaccination.
Keywords: prevention, Swiss primary care, barriers and facilitators, Streptococcus pneumoniae
Introduction
Diseases caused by Streptococcus pneumoniae generate substantial rates of morbidity 
and mortality.1,2 Noninvasive isolates of S. pneumoniae are found in patients with 
acute otitis media or pneumonia. An invasive pneumococcal infection is defined as the 
invasion of bacteria into the bloodstream or into other sterile sites of the body.3 Invasive 
infections with S. pneumoniae are clinically present as pneumonia, sepsis, meningitis, 
or arthritis.4 In Switzerland, the incidence of invasive pneumococcal disease is around 
15/100,000 per year for all inhabitants, around 46/100,000 per year for persons over 
64 years and around 14/100,000 per year for children under the age of 2 years.4 In 
2009, lethality in Switzerland was reported to be 11% of all cases (of which 72% were 
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patients over 64 years) with the highest lethality (20%) in 
cases with a sepsis.4 Resistance rates against antibiotics were 
recorded in around 15% of the isolates with no significant 
change during recent years.4
A 23-valent polysaccharide pneumococcal vaccine 
has been available for 30 years.3 Meta-analyses have 
produced inconsistent results regarding the evidence of the 
effectiveness of pneumococcal vaccination.1,2,5–9 Nevertheless, 
in Switzerland this vaccine is officially recommended by 
the Swiss Federal Office of Public Health10 for all persons 
over 64 years and for all risk patients (whereby persons 
with chronic heart or lung diseases, diabetes, renal failure, 
HIV infection, functional or anatomical asplenia etc, are 
considered risk patients), regardless of their age. In contrast 
to these recommendations, the estimated vaccination rate for 
persons over 64 in Switzerland is around 2%.11 Pneumococcal 
vaccinations are for the most part provided by general 
practitioners (GPs), but additionally, a small number of 
patients get vaccinated during a hospital stay.
Several studies have investigated either patients’ 
resistance to vaccination12–15 or general practitioners’ 
attitudes.12,16,17 The lack of time to verify the immunization 
status of the patient12,18 or competing priorities16 were found to 
be barriers for GPs. Another reason that was reported for the 
low vaccination rate was a considerable lack of knowledge 
about the incidence and the seriousness of the disease, and 
about the recommendation as to which patients should be 
vaccinated.12 One study18 investigated the perceived benefit of 
different vaccinations among GPs in Switzerland; in this study 
pneumococcal vaccination was assessed as the vaccination 
with the lowest benefit. Patients’ barriers were reported as 
a general mistrust in modern medicine,13 lack of awareness 
of the presence of such a disease and its vaccination,12,13 
and factors like avoidance of doctors in general, dislike 
of needles, and forgetfulness.12 Interestingly, three studies 
with older people revealed that they would not accept the 
vaccination in hospital without a previous discussion with, 
and recommendation of their GP.13,14,19 Patients’ general 
refusal of vaccinations were shown to be an important factor 
in some studies,12,16 while in another study, it was mentioned 
as a very rare reason to abstain from a vaccination.18
Even if pneumococcal vaccinations have been assessed in 
several studies, to our knowledge there is no qualitative study 
addressing GPs. Therefore the aim of our qualitative 
study was to investigate individual GP’s views on the 
pneumococcal vaccination. We particularly focus on reasons 
for the known gap between governmental recommendations 
for the pneumococcal vaccination and performance in the 
primary care setting. With our study, we explicitly wanted 
to investigate why the pneumococcal vaccination is so rarely 
provided by GPs.
Methods
Study design, setting, and participants
This qualitative study was conducted during the winter of 
2010/2011 with GPs in primary care practices in the German-
speaking part of Switzerland. The semistructured and open-
ended interviews took place at the GPs’ practices at a time of 
their choice. The interviews were conducted by a staff member 
from the Institute of General Practice at the University of 
Zurich. An interview guide outlined the main aspects of the 
interview. Additional explanations were given when the GP 
did not understand the question. The interviews were recorded 
on a digital audio recorder; the interviewer provided additional 
hand notes. Prior to the start of the study, the interview guide 
was tested with two GPs concerning comprehensibility of the 
questions and logical structure of the interview.
Selection and recruitment
The aim of our study was to understand the perception and 
individual views of GPs concerning the pneumococcal 
vaccination; we did not aim for a quantitative statement, 
therefore, 20 GPs were included in the study.20 With a 
question under study in mind, we decided to analyze with 
qualitative content analysis rather than with grounded theory. 
We sent an information letter to all GPs on a preexisting list 
of our GP research network of 251 GPs who once showed 
interest in participating in research projects. The response 
rate was rather low, with 28 GPs (11.2%) showing interest in 
participation. In Switzerland, the task of primary care differs 
based on geographical factors, especially with respect to the 
work environment of an urban region (where there may be 
many specialists or hospitals around) compared with a rural 
area (where the GP is very often the only physician in a 
broader region). Therefore, the final participants were chosen 
in a way as to obtain a representative balanced distribution 
with respect to rural and urban GPs.
Data analysis
The complete interviews were transcribed, and the transcriptions 
were analyzed following the technique of qualitative content 
analysis,21 supported by the ATLAS.ti© software (ATLAS.ti 
Scientific Software Development GmbH, Berlin, Germany). 
This qualitative method uses categories as the main instrument: 
categories can be built deductively – eg, according to the 
interview guide or based on a clinical framework – as well 
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as inductively – with generation of new coding categories or 
adaption of the categories during coding. In this study, based 
on the structure of the interview guide and our framework, 
a category system was elaborated with only minor adaption 
during the coding process; the categories are shown in Table 1. 
After the coding procedure, a synthesis of all findings was 
compiled in discussions with three researchers. The results 
and conclusions were sent to the participating GPs to ensure 
that the interpretation of the results was consistent with the 
GPs’ original opinions.22 All material from the interviews, the 
member validation, and the following discussions served as 
the basis for the final interpretative work.
Ethical approval
The study protocol was approved by the Ethics Committee of 
Zurich. A written “declaration of no objection” was recorded 
on December 19, 2011.
Results
Results are presented according to the interview guide, 
summarizing some chapters for a better readability.
Participating GPs
As shown in Table 2, the interviewed GPs were between 40 
and 65 years old, with a mean age of 54.7 years, which is a 
little bit higher than the average age (53.3 years) of outpa-
tient doctors in Switzerland.23 Participants had between 7 
and 32 years of practical experience, with a mean of 20.3 
years. Three of the 20 participants were female, 17 were 
male. Sixteen GPs worked full time and four worked part 
time. Thirteen participants worked in an urban or suburban 
region, while seven participants worked in a rural area. 
According to the statistics of the Swiss Medical Board,24 
out of the 5800 general practitioners/general internists, 4262 
(73.5%) were male, so in our sample study, the women are 
slightly underrepresented. Unfortunately there is currently 
no valid statistic on average workload in Swiss primary 
care.
GPs’ evaluation of the pneumococcal 
disease and its vaccination
Most GPs acknowledged that diseases caused by S. pneumoniae 
were potentially severe, with high morbidity and mortality. 
Nevertheless, all GPs stated that they had hardly ever seen 
patients with proven invasive pneumococcal disease in their 
own practice.
I have simply never seen [a pneumococcal infection], 
nor have I ever heard of a patient of mine suffering of an  
[pneumococcal infection]. [GP13, m, 65y]
As a limiting factor, the GPs stated that normally they did 
not take smear tests in patients with respiratory infections, and 
empiric therapy was started without knowing the causative 
organism for the infection. Generally, the vaccination was 
perceived effective by the majority of the GPs, but most of 
the GPs stated that they had no possibility of verifying the 
effectiveness in their daily practice.
I can’t say anything about the effectiveness of the 
vaccination from my daily experience, because I don’t 
know, if a patient really had a pneumococcal disease and 
if this would have been preventable with the vaccination. 
[GP3, m, 48y]
Table 1 Category system for coding
Coding categories and subcategories
  I. Pneumococcal disease 
   A. Evaluation of the pneumococcal disease
II. Pneumococcal vaccination 
   B. Evaluation of the pneumococcal vaccination 
      B1. Evaluation of the effectiveness 
      B2. Evaluation of the side effects 
   C. Basis for the decision for/against the pneumococcal vaccination 
      C1. Ministry of Health/experts’ opinion 
        C2.  Scientific studies 
      C3. Other reasons 
   D.  Indications for the pneumococcal vaccination 
   E. Reasons to omit the pneumococcal vaccination 
      E1. Awareness for the topic too low 
      E2. Time constraints/low priority of the pneumococcal vaccination 
      E3. Unclear data 
      E4. Patient’s refusal 
      E5. Medical contraindications 
      E6. Other reasons 
   F. Interventions to increase the vaccination rate 
      F1. Doctors’ level 
      F2. Patients’ level 
      F3. Other ideas
   G.  Other important aspects
Note: Coding system: categories and subcategories for the coding process used 
with the ATLAS.ti© software.
Table 2 Sociodemographic data of the participants
Attribute Value
Age 40–65 years (mean 54.7 years)
Practice experience 7–32 years (mean 20.3 years)
Sex 15% female (n = 3) 
85% male (n = 17)
Workload 20% part time (n = 4) 
80% full time (n = 16)
Practice region 35% rural (n = 7) 
65% urban/suburban (n = 13)
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None of the GPs had experienced noteworthy side effects 
of the vaccination in their patients.
GPs perceived the data about the epidemiology of 
pneumococcal diseases and the effectiveness of the 
pneumococcal vaccination as too weak.
I think … The data are not really here … That’s my 
impression. [GP5, m, 53y]
Even though most of the GPs stated they had not read 
original studies to assess the epidemiological situation regard-
ing pneumococcal diseases and the efficacy of its vaccination, 
they based their opinions on controversial discussions, for 
example from some experts’ lectures. Furthermore, the GPs’ 
motivation to follow governmental recommendations and 
provide the pneumococcal vaccination was very low.
Finally, we have no program to promote the pneumococcal 
vaccination. I feel the theoretical “It should be done …” but 
not the clear “Do it!” from the government. [GP1, m, 56y]
Overall, GPs stated that of all of the recommended vaccina-
tions, the pneumococcal vaccination was the least important.
Lack of awareness and time constraints 
as barriers
One of the most often stated reasons to omit the pneumococcal 
vaccination was that the GPs simply forgot to discuss the 
vaccination with their patients. There were different reasons 
for this: First, pneumococcal diseases were not considered 
an important problem in daily practice.
The importance is not really given in daily practice … I think 
it is not really perceived as a problem. [GP9, m, 42y]
Second, with most of the patients, other diseases, 
problems, or even other vaccinations were more important 
and had to be solved or discussed first.
For me, it’s just a question of priorities … There are many 
issues that are much more important than the pneumococcal 
vaccination. [GP12, f, 59y]
Due to the permanent time constraints in the GPs’ daily 
practice, after the solving of acute health issues, there was just 
not enough time left to discuss the pneumococcal vaccination. 
Furthermore, none of the GPs had ever had a patient asking 
about the pneumococcal vaccination; GPs stated that some 
patients did not even know this vaccination exists.
Concerning the patients’ opposition to vaccinations, only 
general opposition against vaccinations (mostly with regard 
to the seasonal flu vaccination) was discussed, since the topic 
of a pneumococcal vaccination was often not brought up at 
all. Several GPs stated that in patients where the vaccination 
was actually discussed, opposition was hardly seen.
Interventions to increase  
the pneumococcal vaccination rate
The GPs mentioned several possible interventions that 
could increase the vaccination rate, even though not all of 
them were really convinced that the vaccination rate should 
be increased at all. From a professional perspective, GPs 
proposed an improvement of the data regarding the epide-
miology of the pneumococcal disease and the effectiveness 
of the pneumococcal vaccination.
The vaccination rate could be positively influenced if the 
existing data would be declared clearly and GPs would 
be transparently informed about the benefits and harms of the 
vaccination … Number needed to vaccine, number needed 
to harm … Really proved in good studies … [GP3, m, 48y]
Furthermore, they highlighted the importance of a good 
vaccination campaign, but the discussion about who should 
provide and support this campaign was very controversial: 
half of the GPs wanted the Swiss Federal Office of Public 
Health to conduct such a campaign;
On a doctor’s level, there should be a vaccination campaign 
from the Federal Office of Public Health, once again … 
[GP20, m, 54y],
the other half explicitly did not believe in the success of a 
campaign conducted by the Swiss Federal Office of Public 
Health.
There should be better publicity, but not from the Federal 
Office of Public Health, because this is a suspect authority! 
[GP16, m, 46y].
Taking the patient perspective, GPs proposed a combi-
nation of the pneumococcal vaccination with the influenza 
vaccination campaign, to provide a free vaccination; and to 
sensitize society for the pneumococcal disease via mass media, 
for example with TV commercials or on medical websites.
In medicine, it has always worked if something was brought 
to the mass media… [GP12, f, 59y]
Discussion
Main findings
Despite its being an official recommendation of the Swiss 
Federal Office of Public Health, the vaccination of several 
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population subgroups against pneumococcal diseases, is not 
at all implemented in routine primary care. As reasons for the 
nonadherence to these guidelines, we found a generally low 
priority given to the pneumococcal vaccination, the missing 
awareness for this subject in daily practice, and the perception 
of the epidemiologic and scientific data as insufficient, as 
well as a lack of trust in governmental organizations.
Lack of awareness of pneumococcal 
diseases
Although all participating GPs evaluated diseases caused 
by S. pneumoniae as potentially severe with the risk for 
serious complications, they stated that it is generally not 
perceived as a problem in daily practice. The low level of 
publicity is also represented in the fact that on the patients’ 
side, pneumococcal vaccination had not been mentioned thus 
far. Interestingly, even while most participants mentioned 
general reservation towards vaccinations was very common 
among their patients, they had thus far very seldom had a 
specific opposition to the pneumococcal vaccination. In 
contrast, earlier studies have found patients’ opposition to 
vaccinations to be a relevant patient factor.12,16 The missing 
opposition is, of course, limited by the fact that the subject 
of pneumococcal vaccination is virtually absent during most 
consultations.
In addition, in Switzerland, hospitalization of patients with 
severe health problems is not mandatorily initiated by the GP. 
So most of the patients with a severe pneumococcal infection 
are not seen by their GP, but go directly into the hospital on 
their own. The resulting rarity of the pneumococcal disease 
in daily practice obviously worsens the lack of awareness of a 
GP. The studies by Ridda,13 Mieczkowski,12 and Zimmerman15 
found the lack of knowledge to be a main barrier against the 
pneumococcal vaccination. In our study, we were not testing 
the current knowledge of the participating GPs, therefore, a 
clear differentiation between lack of knowledge and lack of 
awareness was unfortunately not possible.
Low priority of the pneumococcal 
vaccination in daily practice
As stated by the interviewed GPs, among all medical 
problems, the pneumococcal vaccination is quite at the 
end of the list of priorities in daily business. In elderly, 
often polymorbid patients, more acute problems have to 
be solved first. Due to time constraints, there is very often 
no time left to talk about themes of second priority, like 
pneumococcal vaccination or preventive topics in general. 
Consistent with the findings of Bovier et al in 2005,18 most 
of our GPs also rated the pneumococcal vaccination as the 
least important of all vaccinations. In addition, in patients 
with a rather critical attitude to vaccinations in general, GPs 
omitted the discussion of additional vaccinations, like the 
pneumococcal vaccination, to avoid a fundamental refusal 
of the more essential, basic vaccinations. Unfortunately, our 
study design did not allow us to differentiate between the time 
the discussion for a pneumococcal vaccination was actively 
omitted by the GP and when it was simply forgotten due to 
other priorities.
Insufficient epidemiological data
Even though the participating GPs stated that they had not 
read original studies about pneumococcal vaccination, most 
of them mentioned that data regarding the epidemiology 
of the pneumococcal disease and the effectiveness of the 
vaccination were not sufficient to convince doctors and 
patients of the need for vaccination. The majority of the 
GPs formed their opinions regarding vaccinations by 
reading official study summaries or listening to experts’ 
lectures. Obviously these conclusions and lectures were 
not convincing enough to lead these GPs to provide the 
pneumococcal vaccination more often.
All GPs expected clear recommendations for 
physicians from the government and more support for their 
implementation in daily practice. This is an interesting finding 
in light of the already existing recommendations published by 
the Swiss Office of Public Health. Additionally, there was no 
consensus about which (governmental) organization would 
be most effective and have the greatest physician acceptance 
to successfully promote such a campaign.
Implications for future research  
and practice
At the patient level, the GPs proposed the provision of an 
educational campaign about the pneumococcal disease and its 
vaccination, for example over mass media and on an official 
website. Such campaigns are quite common; in Switzerland, an 
annual campaign on seasonal flu vaccination (“flu vaccination 
day”) is organized by the Swiss government in cooperation 
with the Swiss Board of primary care. As uttered by one 
study participant, an extension of the campaign to include 
pneumococcal vaccination would be feasible; especially 
regarding similar target populations. This would most likely 
be accepted by patients and the majority of GPs.
One participant suggested that pneumococcal vaccination 
should be free of charge. Switzerland has a complex system 
with mandatory insurances, but patients must pay a predefined 
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deductible amount of between 300 and 2500 CHF (Swiss 
francs) and an additional 10% of all costs above that amount. 
It can be therefore concluded that overall, most of the patients 
have to pay for the pneumococcal vaccination themselves. 
In adults, this payment system does not differ from other 
vaccinations – unfortunately, valid data about vaccination 
rates (for example, tetanus in adults) is not available. In 2009, 
the vaccination campaign against H1N1 virus was funded 
by the Swiss government and a higher vaccination rate was 
reached. This campaign was also accompanied by a mass 
media campaign. It is not possible to distinguish between 
the effects of the cost of the vaccination and the publicity of 
the disease on the higher rate of vaccinations.
Obviously, the epidemiologic data on vaccination has so 
far not persuaded GPs, and clearer data on the efficiency of 
the vaccination should be obtained. It is questionable as to 
whether a clearer statement by the government alone will raise 
the vaccination rate: First, the guideline is actually already 
very clear. Second, several of the GPs mentioned their mistrust 
of recommendations of the Federal Office. And finally, a 
clearer statement would not change the daily issues of time 
constraints and lack of awareness. Integrating the subject into 
peer discussions might be more reasonable and effective.25,26 
In Switzerland, about half of the GPs are members of primary 
health care networks and are therefore regularly participating 
in “quality circles” (peer-group discussions to improve quality 
of care). This effect might be limited by the fact that quality 
circles are working autonomously and with no regulation of 
scheduled topics. Our study showed a very low priority given 
to the pneumococcal vaccination in daily practice. However 
unfortunately, we could not differentiate between the physician 
actively omitting the subject of pneumococcal vaccination 
and forgetting to bring up the subject during consultation. 
Further interventions such as standing order programs for 
nurses (as exist in the US)27 might also be very promising for 
Swiss primary care. Thus far, delegation to nonphysicians in 
Swiss primary care is seldom done, but in the light of time 
constraints, organizational adjustments in Swiss primary care 
show promising potential.28 Furthermore, intervention such 
as electronic medical record reminders29 might help to bring 
the discussion into the consultation. In 2007, the distribution 
of electronic medical records in primary care was still in its 
infancy in Switzerland,30 but in the future, a higher rate can 
be expected.
Limitations and strength of the study
Our results should be considered with the limitations of 
all qualitative research. The recruiting procedure, with 
registration based on interest, and the low response rate can 
cause a selection bias because maybe only well-informed 
and highly interested GPs agreed to participate. Furthermore, 
with a qualitative study, we collect single opinions, so the 
transfer of our results to other populations is limited. For 
the analysis, we chose a qualitative content analysis rather 
than grounded theory. Both qualitative research methods are 
based on categories: while in qualitative content analysis the 
question of the study is kept in mind and the main findings 
are discussed in a summarized form, the analysis in grounded 
theory is open minded and without a summary of interview 
findings. We offset the hazard of losing information by 
summarizing analyses and categories independently. We 
compared the categories and found a high rate of agreement. 
The strength of a qualitative study is that individual 
experiences and opinions can be investigated to build new 
theories and hypotheses. In that we interviewed GPs with 
very different sociodemographic backgrounds, we were 
able to show a broad spectrum of opinions. Nevertheless, 
we reached a good level of saturation with the number of 
interviews, since in the last interviews, no real new aspects 
were mentioned.
Conclusion
As reasons for the low rate of pneumococcal vaccinations, 
we found a generally low priority given to this within a 
consultation, missing awareness of this subject in daily 
practice, and the perception of the epidemiologic and scientific 
data as insufficient. Efforts to increase the epidemiologic data 
on the pneumococcal vaccination should be invested. To 
increase the vaccination rate, it would be necessary to raise 
the awareness and priority of the pneumococcal vaccination 
with information campaigns for doctors and patients. One 
feasible way could be to combine the seasonal flu vaccination 
campaign with a campaign for pneumococcal vaccination. 
Further interventions such as electronic medical records 
reminders or standing order programs should be the focus 
of future research.
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Interview guide for the in-depth 
interviews
Interview guide for interviews
1.  How do you assess the pneumococcal disease from your 
primary care point of view?
Specification if necessary:
–  Is the disease relevant/frequent in your daily 
practice?
–  Is the pneumococcal disease an overestimated or an 
underestimated disease?
2.  How do you assess the pneumococcal vaccination from 
your primary care point of view, especially regarding its 
effectiveness and its side-effects?
3.  On what do you base your decisions for/against the pneu-
mococcal disease?
4.  During the last years, there have been several studies and 
meta-analyses regarding the pneumococcal vaccination.
– Did you follow the discussions?
–  Do studies generally play an important role for your 
decision for/against the pneumococcal vaccination?
5.  The vaccination rate for pneumococcal diseases is 
 relatively low in Switzerland.
– What do you think are the reasons for this?
– Is this low vaccination rate a problem at all?
–  How could the vaccination rate be increased (if 
necessary)?
6.  Which patients should be vaccinated against pneumococ-
cal diseases in your opinion?
–  What are the reasons to omit the pneumococcal 
vaccination?
7.  What are your experiences with patients regarding the 
pneumococcal vaccination?
Specification if necessary:
–  How many patient come to your practice on their own 
to get vaccinated?
–  How many patients can you convince for the 
vaccination?
– Are there general barriers against the vaccination?
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